4//SEC Filing
Nemec Sarah 4
Accession 0001193125-25-321149
CIK 0001641281other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 5:12 PM ET
Size
42.3 KB
Accession
0001193125-25-321149
Insider Transaction Report
Form 4
Nemec Sarah
Senior VP, Finance and PAO
Transactions
- Award
Employee Stock Option (Right to Buy)
2025-12-12+1,236→ 1,236 totalExercise: $5.44Exp: 2030-09-02→ Common Stock (1,236 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-12-12−1,236→ 0 totalExercise: $86.80Exp: 2030-09-02→ Common Stock (1,236 underlying) - Award
Employee Stock Option (Right to Buy)
2025-12-12+375→ 375 totalExercise: $5.44Exp: 2031-02-03→ Common Stock (375 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-12-12−375→ 0 totalExercise: $400.00Exp: 2031-02-03→ Common Stock (375 underlying) - Award
Employee Stock Option (Right to Buy)
2025-12-12+600→ 600 totalExercise: $5.44Exp: 2031-12-21→ Common Stock (600 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-12-12−600→ 0 totalExercise: $90.20Exp: 2031-12-21→ Common Stock (600 underlying) - Award
Employee Stock Option (Right to Buy)
2025-12-12+2,199→ 2,199 totalExercise: $5.44Exp: 2032-02-17→ Common Stock (2,199 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-12-12−2,199→ 0 totalExercise: $61.60Exp: 2032-02-17→ Common Stock (2,199 underlying) - Award
Employee Stock Option (Right to Buy)
2025-12-12+6,699→ 6,699 totalExercise: $5.44Exp: 2033-01-18→ Common Stock (6,699 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-12-12−6,699→ 0 totalExercise: $27.80Exp: 2033-01-18→ Common Stock (6,699 underlying) - Award
Employee Stock Option (Right to Buy)
2025-12-12+1,589→ 1,589 totalExercise: $5.44Exp: 2034-03-03→ Common Stock (1,589 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-12-12−1,589→ 0 totalExercise: $25.40Exp: 2034-03-03→ Common Stock (1,589 underlying) - Award
Employee Stock Option (Right to Buy)
2025-12-12+2,499→ 2,499 totalExercise: $5.44Exp: 2034-07-22→ Common Stock (2,499 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-12-12−2,499→ 0 totalExercise: $14.60Exp: 2034-07-22→ Common Stock (2,499 underlying) - Award
Employee Stock Option (Right to Buy)
2025-12-12+4,499→ 4,499 totalExercise: $5.44Exp: 2034-07-22→ Common Stock (4,499 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-12-12−4,499→ 0 totalExercise: $14.60Exp: 2034-07-22→ Common Stock (4,499 underlying) - Award
Employee Stock Option (Right to Buy)
2025-12-12+11,299→ 11,299 totalExercise: $5.44Exp: 2035-04-30→ Common Stock (11,299 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-12-12−11,299→ 0 totalExercise: $7.02Exp: 2035-04-30→ Common Stock (11,299 underlying)
Footnotes (13)
- [F1]The option is fully vested and exercisable.
- [F10]For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following July 15, 2024.
- [F11]The reporting person agreed to cancellation of an option granted on July 23, 2024, in exchange for a new option having a lower exercise price.
- [F12]For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2025.
- [F13]The reporting person agreed to cancellation of an option granted on May 1, 2025, in exchange for a new option having a lower exercise price.
- [F2]The reporting person agreed to cancellation of an option granted on September 3, 2020, in exchange for a new option having a lower exercise price.
- [F3]The reporting person agreed to cancellation of an option granted on February 4, 2021, in exchange for a new option having a lower exercise price.
- [F4]The reporting person agreed to cancellation of an option granted on December 22, 2021, in exchange for a new option having a lower exercise price.
- [F5]The reporting person agreed to cancellation of an option granted on February 18, 2022, in exchange for a new option having a lower exercise price.
- [F6]For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2023.
- [F7]The reporting person agreed to cancellation of an option granted on January 19, 2023, in exchange for a new option having a lower exercise price.
- [F8]For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2024.
- [F9]The reporting person agreed to cancellation of an option granted on March 4, 2024, in exchange for a new option having a lower exercise price.
Documents
Issuer
Bolt Biotherapeutics, Inc.
CIK 0001641281
Entity typeother
Related Parties
1- filerCIK 0002023538
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 5:12 PM ET
- Size
- 42.3 KB